Evidence map›Paper›PMID 37938770›Full record

ArticleNature2023

TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons.

Shuai Zhao, Jiuwei Lu, Bo Pan, Huitao Fan, Stephanie D Byrum, Chenxi Xu, Arum Kim, Yiran Guo, Krishna L Kanchi, Weida Gong and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Shuai Zhao *Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
Jiuwei Lu *Department of Biochemistry, University of California, Riverside, CA, USA.ORCID 0000-0002-6478-4081
Bo PanDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-2626-1589
Huitao FanLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.ORCID 0000-0001-8250-3696
Stephanie D ByrumDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID 0000-0002-1783-3610
Chenxi XuDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
Arum KimDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
Yiran GuoDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
Krishna L KanchiLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Weida GongLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.ORCID 0000-0002-0046-9277
Tongyu SunDepartment of Cell Biology, Duke University School of Medicine, Durham, NC, USA.
Aaron J StoreyDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Nathaniel T BurkholderDepartment of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.ORCID 0000-0002-1769-3750
Samuel G MackintoshDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Peyton C KuhlersDepartment of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Ricky D EdmondsonDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Brian D StrahlLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.ORCID 0000-0002-4947-6259
Yarui DiaoDuke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0001-5842-4082
Alan J TackettDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Jesse R RaabLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Ling CaiDuke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
Jikui SongDepartment of Biochemistry, University of California, Riverside, CA, USA. jikui.song@ucr.edu.
Gang Greg WangDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA. greg.wang@duke.edu.ORCID 0000-0002-7210-9940
University of North Carolina at Chapel Hill · USUniversity of Arkansas for Medical Sciences · USDuke University · USUniversity of California, Riverside · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI STEVEN E EALICK · 2018 to 2026
$34.2M
Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Alan Tackett · 2017 to 2026
$27.6M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
Mechanisms of chromatin and transcriptional regulationR35GM126900 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian D Strahl · 2018 to 2026
$5.5M
Mechanistic Insights into Mammalian DNA MethylationR35GM119721 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Jikui Song · 2016 to 2026
$5.3M
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged LeukemiasR01CA268384 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jian Jin, G Greg Wang · 2022 to 2026
$3.9M
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in canerR01CA268519 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jian Jin, G Greg Wang · 2022 to 2026
$3.2M
The 4D nucleome of muscle regeneration in ischemia-induced tissue damage and repairU01HL156064 · NHLBI · DUKE UNIVERSITY · PI DIAO, YARUI · 2020 to 2024
$3.0M
The role for phase separation in oncogenesis and aberrant chromatin looping formationR01CA271603 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Douglas H. Phanstiel, G Greg Wang · 2022 to 2026
$2.9M
Multi-omics functional analysis of non-coding regulatory genome for genomic medicineR35HG011328 · NHGRI · DUKE UNIVERSITY · PI DIAO, YARUI · 2020 to 2024
$2.3M
Mechanisms of SWI/SNF complex assembly and functionR35GM147286 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jesse R. Raab · 2022 to 2026
$2.1M
NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA236209NCI NIH HHS R01 CA262903NCI NIH HHS R01 CA268384NCI NIH HHS R01 CA268519NCI NIH HHS R01 CA271603NHGRI NIH HHS R35 HG011328NHLBI NIH HHS U01 HL156064NIGMS NIH HHS P20 GM121293NIGMS NIH HHS P30 GM124165NIGMS NIH HHS R24 GM137786NIGMS NIH HHS R35 GM119721NIGMS NIH HHS R35 GM126900NIGMS NIH HHS R35 GM147286
6 · The paper itself

Abstract

Trimethylation of histone H3 lysine 9 (H3K9me3) is crucial for the regulation of gene repression and heterochromatin formation, cell-fate determination and organismal development

Indexed as

Endogenous RetrovirusesGene SilencingHistonesIntracellular Signaling Peptides and ProteinsLysineRetroelementsAnimalsAnimals, NewbornCell LineChromatinCo-Repressor ProteinsEpigenesis, GeneticGene Expression ProfilingGenomeHistone DeacetylasesHumansChromatinCo-Repressor ProteinsHistone DeacetylasesHistonesIntracellular Signaling Peptides and ProteinsLysineRetroelementsTNRC18 protein, humanTnrc18 protein, mouse

Identifiers

PMID37938770
PMCPMC11000523
OpenAlexW4388488603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.